Ocular diseases

Ophthalmic Drugs

28th – 29th November 2017, London, UK

Ophthalmic Drugs will gather industry leaders to discuss the latest challenges and changes in the field of ophthalmology. Explore novel approaches to treatment, ocular medical devices, targeted drug delivery technology and real-life challenges to pre-clinical and clinical trials, to deepen your understanding of inherited ocular diseases.

 

Read more: Ophthalmic Drugs
Clinical Trials

Global Clinical Connect 2017

2nd - 3rd November, 2017, London, UK

The Global Clinical Connect 2017 (GCC’17) conference focuses on introducing pioneer technology, developing better patient engagement and collaborating strategies in clinical trials. With the right commitment and attention to detail, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency.

Read more: Global Clinical Connect 2017
Medical Device Design conference

3rd Annual Human Factors Excellence for Medical Device Design

9th - 10th August, 2017, Minneapolis, MN, USA

The 3rd Annual Human Factors Excellence for Medical Device Design conference will engage with leading practitioners to share relevant techniques to improve human factors in Medical Device design in order to decrease user-related risk and develop safer products.

Read more: Human Factors Excellence for Medical Device Design Conference
Biosimilars

4th Biosimilars North America


15-16 November 2017, Iselin, New Jersey

Building on the success of previous events, SMi proudly announces the return of its 4th annual Biosimilars North America Conference, taking place on November 15 and 16, 2017 in Iselin, New Jersey.

 

Read more: 4th Biosimilars North America
Biosimilars and Biobetters

Biosimilars & Biobetters 

27th & 28th September, London UK

As the patents for several innovator biologics expire, biopharmaceutical companies are taking the opportunity to develop more affordable forms creating a rapidly booming biosimilars market. However, as the field of biosimilars evolves, challenges in immunogenicity studies, securing market share, exclusivity and regulations still persist.

Read more: Biosimilars & Biobetters 2017
Collagen Conference

Word Collagen Conference

6-7 September 2017, in London, UK

Increasing consumer consciousness towards health and personal care coupled with rising trend for nutraceutical products are expected to fuel the growth of Collagen. Improving standard of living and growing fitness consciousness are likely to be the key drivers to propel demand. Global collagen market size was valued at more than USD 3 billion in 2015 and is likely to exceed USD 5 billion by 2023, growing at a CAGR of more than 7% from 2016 to 2023.

Read more: Word Collagen Conference

Featured Events

 
 
150x150
 
collagen 150x150
 150 x 150 copy
 150x150ophta
 
150x150Fazmina 1